Drug Discovery Technologies Global Market Report 2024

Description

Drug discovery technology encompasses a range of techniques and strategies employed in the identification of new drugs and the recognition of chemical entities with potential therapeutic applications. These methodologies are geared towards pinpointing and developing potential drug candidates for the treatment of various diseases.

The primary categories of drug discovery technologies include high-throughput screening, genomics, nanotechnology, bioinformatics, combinational chemistry, pharmacogenomics, biochips, bioanalytical instruments, and ribonucleic acid interface (RNAI). High-throughput screening is a method designed to rapidly assess the biological activity of numerous samples, expediting the drug discovery process. These technologies find application in the discovery of drug types such as small molecule drugs and biologic drugs, addressing conditions such as cancer, immunological disorders, neurological ailments, cardiovascular diseases, and others. Pharmaceutical companies, biopharmaceutical companies, biotechnology firms, research institutes, and other entities utilize these technologies for drug discovery purposes.

The drug discovery technologies research report is one of a series of new reports from The Business Research Company that provides drug discovery technologies market statistics, including the drug discovery technologies global market size, regional shares, competitors with a drug discovery technologies market share, detailed drug discovery technologies market segments, market trends and opportunities, and any further data you may need to thrive in the drug discovery technologies. This drug discovery technologies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The drug discovery technologies market size has grown rapidly in recent years. It will grow from $66.08 billion in 2023 to $72.87 billion in 2024 at a compound annual growth rate (CAGR) of 10.3%. The growth observed in the historical period can be attributed to the expansion of genomic and proteomic research, heightened comprehension of molecular biology, the growth of combinatorial chemistry, the adoption of bioinformatics and computational approaches, and the emergence of targeted therapies.

The drug discovery technologies market size is expected to see rapid growth in the next few years. It will grow to $108.31 billion in 2028 at a compound annual growth rate (CAGR) of 10.4%. The anticipated growth in the forecast period can be attributed to the adoption of CRISPR for gene editing, the expansion of precision medicine approaches, the application of omics technologies in drug development, the utilization of quantum computing in drug discovery, and the rise of patient-derived xenograft (PDX) models. Key trends in the forecast period include advancements in high-throughput screening, the development of automated laboratory equipment, collaboration between academic and industry research, technological advances in imaging and microscopy, the integration of artificial intelligence in drug discovery, 3D cell culture technologies, the adoption of machine learning in drug design, collaboration between pharmaceutical companies and tech startups, and the integration of blockchain for data security.

The anticipated increase in the prevalence of acute and chronic diseases is poised to drive the drug discovery technologies market in the future. Chronic diseases, which persist for a year or more and necessitate ongoing medical attention, have witnessed numerous innovative treatments through advancements in drug discovery technologies and drug development. The incorporation of emerging technologies such as digital health tools, artificial intelligence (AI), and machine learning in the drug research and development (R&D) process presents opportunities to overcome critical barriers and streamline clinical trials for prevalent chronic diseases. As of May 2023, according to The United Nations (UN), chronic diseases accounted for seven out of 10 deaths in the US, resulting in over 1.7 million annual fatalities. Hence, the escalating prevalence of acute and chronic diseases is expected to be a driving force for the drug discovery technologies market.

The increase in healthcare expenditures is anticipated to propel the growth of the drug discovery technologies market. Healthcare expenditures encompass all costs associated with providing health services, family planning activities, nutrition programs, and emergency assistance with a focus on health. A surge in healthcare spending supports research and development, fostering the expansion of drug discovery technologies through the funding of advanced technologies and infrastructure. For instance, in December 2023, as reported by the Centers for Medicare & Medicaid Services, US healthcare spending witnessed a 4.1% increase in 2022, reaching $4.5 trillion, or $13,493 per person, constituting 17.3% of the country's gross domestic product. Consequently, the rise in healthcare expenditures is a significant driver for the growth of the drug discovery technologies market.

The emergence of advanced technologies stands out as a prominent trend in the drug discovery technologies market. Major companies in this sector are actively introducing sophisticated technologies to maintain their market positions. In May 2023, Google LLC, a US-based technology company, unveiled the Target and Lead Identification Suite-an AI-based tool designed to expedite drug discovery. This tool aids businesses in anticipating and understanding protein structure, a critical element in drug research, by assisting researchers in ingesting, storing, analyzing, and sharing vast volumes of genetic data. The Suite is anticipated to save considerable time and money in the drug development process, addressing a longstanding challenge in the biopharmaceutical sector.

Major companies operating in the drug discovery technologies market are concentrating on advanced solutions, such as drug research and development platforms, to enhance precision in high-throughput analysis. A drug research and development platform serve as a systematic framework for discovering, designing, testing, and bringing pharmaceutical compounds to market. For example, in July 2023, Dotmatics Inc., a US-based scientific software company focused on research and development, launched the Small Molecule Drug Discovery Solution. This comprehensive platform, equipped with pre-configured workflows and enhanced data management features, aims to foster collaboration, boost productivity, streamline operations, and expedite the transformation of data into actionable insights. This advancement accelerates the development of life-enhancing drug therapies by providing researchers with targeted capabilities and templates for a cohesive workspace spanning hit discovery to lead optimization research.

In August 2021, Bayer AG, a Germany-based pharmaceutical company, completed the acquisition of Vividion Therapeutics for approximately $1.5 billion. This strategic move is intended to provide Bayer with novel approaches for small-molecule drug discovery and access to advanced drug discovery programs focused on inhibitors and activators. Vividion Therapeutics, a US-based biotechnology company, is dedicated to discovering and developing selective small molecule medicines targeting traditionally inaccessible disease targets.

Major companies operating in the drug discovery technologies market report are F. Hoffmann-La Roche AG, Novartis AG, Thermo Fisher Scientific Inc., AstraZeneca plc., Merck KGaA, GE HealthCare Technologies Inc., Agilent Technologies Inc., Dassault Systemes SA, Charles River Laboratories International Inc., Bio-Rad Laboratories Inc., Evotec SE, Curia Global Inc., Aragen Life Sciences Private Limited, Luminex Corporation, BioXcel Therapeutics Inc., Certara Inc., Schrodinger Inc., Sygnature Discovery Ltd., Recursion Pharmaceuticals Inc., InSilico Medicine Inc., ChemAxon Ltd., Enamine Ltd., BenevolentAI Limited, OpenEye Scientific Software Inc., Collaborative Drug Discovery Inc., Pharmacelera S.L., Gyros Protein Technologies AB, Optibrium Ltd., Cresset Group, Relay Therapeutics Inc.

North America was the largest region in the drug discovery technologies market in 2023. The regions covered in the drug discovery technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the drug discovery technologies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The drug discovery technologies market consists of revenues earned by entities by drug screening, predictive analytics, modeling, simulation, and computational capabilities. The market value includes the value of related goods sold by the service provider or included within the service offering. The drug discovery technologies market also includes sales of automation tools, computational chemistry software, imaging software, and mass spectrometers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drug Discovery Technologies Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drug discovery technologies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug discovery technologies ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The drug discovery technologies market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Technology: High Throughput Screening; Genomics; Nanotechnology; Bioinformatics; Combinational Chemistry; Pharmacogenomics; Biochips; Bioanalytical Instruments; Ribonucleic Acid Interface (RNAI)
2) By Drug Type: Small Molecule Drugs; Biologic Drugs
3) By Disease Application: Cancer Diseases; Immunological Diseases; Neurological Diseases; Cardiovascular Diseases; Other Disease Applications
4) By End-User: Pharmaceutical Companies; Biopharmaceutical Companies; Biotechnology Companies; Research Institutes; Other End-Users
Companies Mentioned: F. Hoffmann-La Roche AG; Novartis AG; Thermo Fisher Scientific Inc.; AstraZeneca plc.; Merck KGaA
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r14209

1. Executive Summary

2. Drug Discovery Technologies Market Characteristics

3. Drug Discovery Technologies Market Trends And Strategies

4. Drug Discovery Technologies Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Drug Discovery Technologies Market Size and Growth

5.1. Global Drug Discovery Technologies Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Drug Discovery Technologies Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Drug Discovery Technologies Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Drug Discovery Technologies Market Segmentation

6.1. Global Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
High Throughput Screening
Genomics
Nanotechnology
Bioinformatics
Combinational Chemistry
Pharmacogenomics
Biochips
Bioanalytical Instruments
Ribonucleic Acid Interface (RNAI)
6.2. Global Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Small Molecule Drugs
Biologic Drugs
6.3. Global Drug Discovery Technologies Market, Segmentation By Disease Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Cancer Diseases
Immunological Diseases
Neurological Diseases
Cardiovascular Diseases
Other Disease Applications
6.4. Global Drug Discovery Technologies Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Pharmaceutical Companies
Biopharmaceutical Companies
Biotechnology Companies
Research Institutes
Other End-Users

7. Drug Discovery Technologies Market Regional And Country Analysis

7.1. Global Drug Discovery Technologies Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Drug Discovery Technologies Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Drug Discovery Technologies Market

8.1. Asia-Pacific Drug Discovery Technologies Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Drug Discovery Technologies Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Drug Discovery Technologies Market

9.1. China Drug Discovery Technologies Market Overview
9.2. China Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Drug Discovery Technologies Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Drug Discovery Technologies Market

10.1. India Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Drug Discovery Technologies Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Drug Discovery Technologies Market

11.1. Japan Drug Discovery Technologies Market Overview
11.2. Japan Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Drug Discovery Technologies Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Drug Discovery Technologies Market

12.1. Australia Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Drug Discovery Technologies Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Drug Discovery Technologies Market

13.1. Indonesia Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Drug Discovery Technologies Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Drug Discovery Technologies Market

14.1. South Korea Drug Discovery Technologies Market Overview
14.2. South Korea Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Drug Discovery Technologies Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Drug Discovery Technologies Market

15.1. Western Europe Drug Discovery Technologies Market Overview
15.2. Western Europe Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Drug Discovery Technologies Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Drug Discovery Technologies Market

16.1. UK Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Drug Discovery Technologies Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Drug Discovery Technologies Market

17.1. Germany Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Drug Discovery Technologies Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Drug Discovery Technologies Market

18.1. France Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Drug Discovery Technologies Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Drug Discovery Technologies Market

19.1. Italy Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Drug Discovery Technologies Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Drug Discovery Technologies Market

20.1. Spain Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Drug Discovery Technologies Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Drug Discovery Technologies Market

21.1. Eastern Europe Drug Discovery Technologies Market Overview
21.2. Eastern Europe Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Drug Discovery Technologies Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Drug Discovery Technologies Market

22.1. Russia Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Drug Discovery Technologies Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Drug Discovery Technologies Market

23.1. North America Drug Discovery Technologies Market Overview
23.2. North America Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Drug Discovery Technologies Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Drug Discovery Technologies Market

24.1. USA Drug Discovery Technologies Market Overview
24.2. USA Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Drug Discovery Technologies Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Drug Discovery Technologies Market

25.1. Canada Drug Discovery Technologies Market Overview
25.2. Canada Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Drug Discovery Technologies Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Drug Discovery Technologies Market

26.1. South America Drug Discovery Technologies Market Overview
26.2. South America Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Drug Discovery Technologies Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Drug Discovery Technologies Market

27.1. Brazil Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Drug Discovery Technologies Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Drug Discovery Technologies Market

28.1. Middle East Drug Discovery Technologies Market Overview
28.2. Middle East Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Drug Discovery Technologies Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Drug Discovery Technologies Market

29.1. Africa Drug Discovery Technologies Market Overview
29.2. Africa Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Drug Discovery Technologies Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Drug Discovery Technologies Market Competitive Landscape And Company Profiles

30.1. Drug Discovery Technologies Market Competitive Landscape
30.2. Drug Discovery Technologies Market Company Profiles
- 30.2.1. F. Hoffmann-La Roche AG
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Novartis AG
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Thermo Fisher Scientific Inc.
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. AstraZeneca plc.
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Merck KGaA
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Drug Discovery Technologies Market Other Major And Innovative Companies

31.1. GE HealthCare Technologies Inc.
31.2. Agilent Technologies Inc.
31.3. Dassault Systemes SA
31.4. Charles River Laboratories International Inc.
31.5. Bio-Rad Laboratories Inc.
31.6. Evotec SE
31.7. Curia Global Inc.
31.8. Aragen Life Sciences Private Limited
31.9. Luminex Corporation
31.10. BioXcel Therapeutics Inc.
31.11. Certara Inc.
31.12. Schrodinger Inc.
31.13. Sygnature Discovery Ltd.
31.14. Recursion Pharmaceuticals Inc.
31.15. InSilico Medicine Inc.

32. Global Drug Discovery Technologies Market Competitive Benchmarking

33. Global Drug Discovery Technologies Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Drug Discovery Technologies Market

35. Drug Discovery Technologies Market Future Outlook and Potential Analysis

35.1 Drug Discovery Technologies Market In 2028 - Countries Offering Most New Opportunities
35.2 Drug Discovery Technologies Market In 2028 - Segments Offering Most New Opportunities
35.3 Drug Discovery Technologies Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer